Rubedo Life Sciences Awarded $1.45M in Funding From CIRM
Rubedo Life Sciences, a biopharmaceutical company focused on developing first-in-class therapies for chronic age-related diseases that target senescent cells that drive cellular aging, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $1.45 million grant. This grant will help fund research and development of a pharmacological regenerative treatment for … Read more